Cannabis Retailers Get Regulatory Window To Separate Medical Licenses Under New California Rule

California cannabis regulator opted for a move that seems to be helping cannabis retailers to set up a standalone medical license structure before the DEA’s registration deadline in relation to ongoing federal cannabis rescheduling and registration developments.

In a Friday press release, the Department of Cannabis Control provided a notice of the adoption of emergency regulations, allowing licensees that are holders of adult-use (A-) and medicinal-use (M-) designated licenses to modify the license to an A-license and a new separate M-license.

Under the new rules, the new medical (M) license can be in the ownership of a different legal entity than the current combined license, with the ownership matching between the existing license and the new M-license.

The state regulator emphasized that the two licenses can’t share the same FEIN or CDTFA seller’s permit number.

The information required for the request includes the existing business’s legal name and license number, the related entity’s legal name, FEIN, and CDTFA seller’s permit number, as well as the related entity’s business formation documents.

The designated responsible party (DRP) must submit either Form 9207 (Request to Separate M-Designation Retail License) or an email containing the required information and supporting documents.

The request must be sent from the DRP’s email address on file with DCC, the state regulator said. Businesses are encouraged to apply as soon as possible, as the DEA’s priority registration window closes on June 26, 2026.

The California guidance arrives as operators across the country evaluate how federal medical cannabis rescheduling could reshape licensing structures, tax treatment, banking relationships, and access to capital. These issues are expected to be among the key topics discussed at the Chicago Cannabis Capital Conference on June 15–16, where regulators, operators, investors, and advisors will examine how businesses can position themselves for an increasingly complex—and potentially more institutional—cannabis market.